Latest Breaking News On - வரைபடம் மருந்து பலகை - Page 1 : comparemela.com

Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) News provided by Share this article Share this article CAMBRIDGE, Mass., April 7, 2021 /PRNewswire/ Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on April 1, 2021, the Compensation Committee of Blueprint Medicines Board of Directors granted non-qualified stock options to purchase an aggregate of 27,543 shares of its common stock and an aggregate of 13,792 restricted stock units (RSUs) to 14 new employees under Blueprint Medicines 2020 Inducement Plan. The 2020 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Blueprint Medicines, as an inducement material to such individual s entering into employment with Blueprint Medicines, pursuant to Rule 5635(c)(4) of t

United statesUnited kingdomBlueprint medicines corporationPrnewswire blueprint medicines corporationMedicines corporationCompensation committeeBlueprint medicine boardBlueprint medicineBlueprint medicinesஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்வரைபடம் மருந்துகள் நிறுவனம்மருந்துகள் நிறுவனம்இழப்பீடு குழுவரைபடம் மருந்து பலகைவரைபடம் மருந்து